Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Techne

60.61
+0.27000.45%
Post-market: 60.930.3200+0.53%18:12 EDT
Volume:2.58M
Turnover:156.29M
Market Cap:9.58B
PE:61.86
High:61.14
Open:59.97
Low:59.45
Close:60.34
Loading ...

Company Profile

Company Name:
Bio-Techne
Exchange:
NASDAQ
Establishment Date:
1976
Employees:
3100
Office Location:
614 McKinley Place N.E.,Minneapolis,Minnesota,United States
Zip Code:
55413
Fax:
612 656 4400
Introduction:
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Directors

Name
Position
Kim Kelderman
President, Chief Executive Officer and Director
Robert V. Baumgartner
Chairman of the Board and Director
Amy E. Herr
Independent Director
Alpna Seth
Director
John L. Higgins
Director
Joseph D. Keegan
Director
Judith Klimovsky
Director
Julie Bushman
Director
Roeland Nusse
Director
Rupert Vessey
Director

Shareholders

Name
Position
Kim Kelderman
President, Chief Executive Officer and Director
James T. Hippel
Executive Vice President – Finance and Chief Financial Officer
Shane Bohnen
Senior Vice President – General Counsel and Corporate Secretary
Matthew F. McManus
President – Diagnostics and Genomics
William Geist
President – Protein Sciences